<?xml version="1.0" encoding="UTF-8"?>
<ref id="B38-molecules-25-03830">
 <label>38.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Durdagi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Aksoydan</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Dogan</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Sahin</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Shahraki</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Birgül-İyison</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike Receptor-Binding Domain Bound with ACE2 COVID19 Target Proteins: A Virtual Drug Repurposing Study</article-title>
  <source>ChemRxiv</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.26434/chemrxiv.12032712.v2</pub-id>
 </element-citation>
</ref>
